Good
Mostly Aligned
Patient Risk:
Low
Summary
Two claims (generic availability and multiple strengths) are unsupported by the label; one claim (tablet formulation) is supported. Overall alignment is Good.
Category Scores
Accurate Statements
Formulation (tablet vs. other forms, if applicable in your market)
3. Dosage Forms and Strengths; Description
Unsupported Statements
Allopurinol is widely available as a generic medicine.
The label describes a branded product (ZYLOPRIM) and does not discuss generic status.
Allopurinol commonly comes in multiple strengths (for example, 100 mg and 300 mg tablets).
The label lists only 100 mg per tablet and does not mention other strengths.
Contradictions
Important Omissions
Generic availability status of allopurinol
Importance:
Moderate
Other available strengths (e.g., 300 mg) not mentioned on the label
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The claims evaluated are about formulation and product status; no safety signals assessed.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Omissions regarding generic status and other available strengths.
Suggested Improvement
Clarify generic status and list all available strengths if in scope of the label; cite the relevant dosage forms/strengths sections.